Mitsubishi UFJ Asset Management (UK)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,000
Closed -$273K 111
2025
Q1
$273K Sell
4,000
-2,000
-33% -$163K 0.15% 98
2024
Q4
$467K Buy
6,000
+5,000
+500% +$370K 0.21% 88
2024
Q3
$67K Sell
1,000
-4,000
-80% -$328K 0.03% 113
2024
Q2
$567K Buy
5,000
+2,000
+67% +$253K 0.29% 77
2024
Q1
$416K Buy
+3,000
New +$377K 0.21% 89
2023
Q4
Sell
-2,000
Closed -$187K 87
2023
Q3
$187K Sell
2,000
-19,000
-90% -$2.14M 0.13% 95
2023
Q2
$2.7M Hold
21,000
1.74% 13
2023
Q1
$2.44M Buy
+21,000
New +$2.35M 1.58% 17
2022
Q2
Sell
-18,000
Closed -$2.3M 86
2022
Q1
$2.3M Buy
+18,000
New +$1.97M 1.04% 35

Other funds holding DXCM

Mitsubishi UFJ Asset Management (UK)'s DXCM Position: Q2 2025 in Review

Mitsubishi UFJ Asset Management (UK) sold out of DexCom (DXCM) in Q2 2025, closing a stake of 4,000 shares — an estimated $273K sold.

Mitsubishi UFJ Asset Management (UK) first reported a position in DXCM in Q1 2022 and held it in 9 quarters. The position peaked at $2.7M in Q2 2023. 940 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Mitsubishi UFJ Asset Management (UK) reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Mitsubishi UFJ Asset Management (UK) sold 4,000 DexCom shares in Q2 2025, an estimated $273K.
  • Mitsubishi UFJ Asset Management (UK) first reported a position in DexCom in Q1 2022 and held it in 9 quarters.
  • Mitsubishi UFJ Asset Management (UK)'s DexCom position peaked at $2.7M in Q2 2023.
  • 940 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Mitsubishi UFJ Asset Management (UK)'s 13F filing for Q2 2025, filed 18 Jul 2025.